SEC Form 4 · accession 0001144204-16-121338
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip P. Chan
Officer — President and CEO · Director
Period of report
Aug 24, 2016
Accepted (ET)
Aug 26, 2016 · 11:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2016 | P | 5,000 | $4.89 | A | 121,648 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Open market purchase.